For infusion, oncology & specialty practices
Every denial, checked every month.
Payer Surveillance reads every denial your practice receives, finds where the payer contradicted itself, and ranks what to file first. Appeal packages turn the strongest into letters ready to send.
✓ First claim free
✓ No EHR access
✓ Never a percentage of recoveries
Drug manufacturer?
Payer Surveillance · Monthly report
One practice · One month
Financial impact and recovery
$173,619
Recoverable revenue identified this period
8
4
3
50+
100%
Recoverable value by pattern
Pattern
Claims
Value
Fee schedule lag · J9011 / CO-96
3
$79,380
Authorization-to-claims disconnect
3
$73,632
California statutory violations · IMR
2
$20,607
Period total
8
$173,619
Priority filing sequence
Tier 1 · Immediate
File within 14 days
$20,607
Tier 2 · Consolidated
File within 30 days
$79,380
Tier 3 · Consolidated
File within 45 days
$73,632
One practice. One month.
About $174K
recoverable, found at one practice in one month of Payer Surveillance: eight claims.
Source: Payer Surveillance report, one practice, one month
50–60%
of post-approval denials for one oncology drug were written off without an appeal, most still inside the filing window.
Source: Enhertu J9358 payer report, Q2 2026 ↗
See it work
See the system in 60 seconds.
A walkthrough of the practice portal: a claim’s contradiction, its appeal, and the monthly report that ranks them all.
How it works
The same three steps, every month.
01
Send the month’s denials
Upload or email the month’s paperwork: denial and uphold letters, EOBs or 835s, authorizations and portal responses. PDFs or screenshots are fine.
No EHR connection
02
Get the ranked report
Every denial checked: where the payer contradicted itself, what’s recoverable and the date to file by, ranked by what to file first.
Payer Surveillance, every month
03
File with an appeal package
Finished letters for the claims worth the most, built from the payer’s own words and ready to sign and send.
Monthly packages of 10, 25 or 50
Real work, anonymized
Read our work before you send us anything.
These are actual filings and reports, with patient and practice details removed.
Appeal filing · PDF
TRI-124: commercial-payer post-exhaustion escalation
Four claims denied and reversed in full. Contracted payments on the same claims the payer called non-contracted, an authorization denied the next day, and three reasons in 65 days.
Read the filing ↗
Drug report · PDF
Enhertu J9358
Seven denial patterns across major commercial payers, with recovery paths for each.
Read the report ↗
For drug manufacturers
You can see what was ordered. Now see inside the claim.
Veriscope shows market access and field reimbursement teams what happens after the authorization clears: where courses of therapy stop, which payers deny and why, site by site. Network views are de-identified.
01
Network view
Every enrolled treatment site in one place: open denials, interrupted courses and the dollars at stake.
02
Payer behavior scores
How each payer handles your drug: where it denies, how its reasons shift, and how long cases take to resolve.
03
Quarterly report
A network payer intelligence report every quarter, built from the correspondence inside the claim.
Pricing
Simple pricing. Never a percentage of what you recover.
Monthly Surveillance, plus a monthly appeal package for the letters.
Every month
Payer Surveillance
Every denial checked monthly, priced by how many denials you have.
From $250
/month
Appeal packages
Appeals
Filing-ready appeal letters, built from the payer’s own documents.
From $1,500
/month for 10 appeals
What do I get free?
Your first claim is free: the full analysis and a filing-ready appeal letter. Surveillance starts at $250 a month.
What do I need to send?
Do you need access to our EHR or clearinghouse?
We already have a billing company. Why add this?
How do you protect patient information?
Payer Surveillance